Product NDC: | 58809-729 |
Proprietary Name: | NASOPEN |
Non Proprietary Name: | Phenylephrine Hydrochloride, Thonzylamine Hydrochloride |
Active Ingredient(s): | 10; 50 mg/15mL; mg/15mL & nbsp; Phenylephrine Hydrochloride, Thonzylamine Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | LIQUID |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 58809-729 |
Labeler Name: | GM Pharmaceuticals, Inc |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part341 |
Marketing Category: | OTC MONOGRAPH FINAL |
Start Marketing Date: | 20121003 |
Package NDC: | 58809-729-04 |
Package Description: | 118 mL in 1 BOTTLE (58809-729-04) |
NDC Code | 58809-729-04 |
Proprietary Name | NASOPEN |
Package Description | 118 mL in 1 BOTTLE (58809-729-04) |
Product NDC | 58809-729 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Phenylephrine Hydrochloride, Thonzylamine Hydrochloride |
Dosage Form Name | LIQUID |
Route Name | ORAL |
Start Marketing Date | 20121003 |
Marketing Category Name | OTC MONOGRAPH FINAL |
Labeler Name | GM Pharmaceuticals, Inc |
Substance Name | PHENYLEPHRINE HYDROCHLORIDE; THONZYLAMINE HYDROCHLORIDE |
Strength Number | 10; 50 |
Strength Unit | mg/15mL; mg/15mL |
Pharmaceutical Classes |